Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushingTaku Sakurai, Matt Barnes, Stuart Stafford et al.|European Journal of Pharmacology|2014Cited by 54
CVN766 – Selective Ox1R antagonist shows efficacy in pre-clinical models of schizophreniaNicola Brice, Mark Carlton, Louise Dickson et al.|Neuroscience Applied|2023Cited by 0